Difference between revisions of "Epidermal growth factor receptor inhibitors"

Revision as of 16:13, 29 March 2012

Epidermal growth factor receptor inhibitors, abbreviated EGFR inhibitors, is a class of drugs that blocks the EGF receptor.

Note:

Both gefitinib and erlotinib are also classified as tyrosine kinase inhibitors (TKIs).

↑ ^1.0 ^1.1 Sun Y, Ren Y, Fang Z, et al. (October 2010). "Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases". J. Clin. Oncol. 28 (30): 4616–20. doi:10.1200/JCO.2010.29.6038. PMID 20855837.

@@ Line 3: / Line 3: @@
 ==Drugs==
 *[[Gefitinib]] (Iressa).<ref name=pmid20855837/>
-*[[Erlotinib]] (Tarceva)).<ref name=pmid20855837>{{cite journal |author=Sun Y, Ren Y, Fang Z, ''et al.'' |title=Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases |journal=J. Clin. Oncol. |volume=28 |issue=30 |pages=4616–20 |year=2010 |month=October |pmid=20855837 |doi=10.1200/JCO.2010.29.6038 |url=}}</ref>
+*[[Erlotinib]] (Tarceva).<ref name=pmid20855837>{{cite journal |author=Sun Y, Ren Y, Fang Z, ''et al.'' |title=Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases |journal=J. Clin. Oncol. |volume=28 |issue=30 |pages=4616–20 |year=2010 |month=October |pmid=20855837 |doi=10.1200/JCO.2010.29.6038 |url=}}</ref>
 Note:
@@ Line 11: / Line 11: @@
 *[[Lung adenocarcinoma]].
 *[[Colorectal adenocarcinoma]].
+*[[Cancer drugs]].
 ==References==